Natural Alternatives International (NAII) Stock Price, News & Analysis

Company Overview

Natural Alternatives International, Inc. (NASDAQ: NAII) is a developer and contract manufacturer of nutritional supplements and related health products. Founded in 1980 and headquartered in Carlsbad, California, the company specializes in turnkey solutions for dietary supplement and functional food brands, combining scientific research with large-scale production capabilities.

NAII’s product portfolio spans a wide range of dosage forms, including softgels, tablets, capsules, powders, effervescent drink mixes and chewables. Its service offerings extend from formulation and analytical method development to stability testing, regulatory support and custom packaging, enabling clients to move seamlessly from concept through commercialization.

The company’s primary manufacturing facility is registered with the U.S. Food and Drug Administration and operates under current Good Manufacturing Practices (cGMP). In addition to its Carlsbad operations, NAII partners with distribution and logistics networks to serve markets across North America, Europe and the Asia-Pacific region, ensuring global supply chain reliability.

Guided by a management team with deep expertise in nutrition science, pharmaceutical manufacturing and quality assurance, Natural Alternatives International maintains a focus on innovation, safety and regulatory compliance. Through ongoing investment in research and collaboration with brand owners, the company seeks to support the development of differentiated, science-backed wellness products.

Key Stats

• Today's Range: $2.69 to $2.83
• 50-Day Range: $2.56 to $2.84
• 52-Week Range: $2.33 to $4.96
• Volume: 12,603 shs
• Average Volume: 18,533 shs
• Market Capitalization: $16.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Natural Alternatives International Stock Analysis - MarketRank™

Natural Alternatives International scored higher than 35% of companies evaluated by MarketBeat, and ranked 736th out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Natural Alternatives International has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Natural Alternatives International has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Natural Alternatives International is -1.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Natural Alternatives International is -1.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Natural Alternatives International has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.07% of the float of Natural Alternatives International has been sold short.

Short Interest Ratio / Days to Cover

Natural Alternatives International has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Natural Alternatives International has recently decreased by 32.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Natural Alternatives International does not currently pay a dividend.

Dividend Growth

Natural Alternatives International does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.96

News Sentiment

Natural Alternatives International has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Natural Alternatives International this week, compared to 1 article on an average week.

Company Ownership

• Score: 4.0 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $25,417.00 in company stock, which represents 0.1523% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Natural Alternatives International insiders have bought more of their company's stock than they have sold. Specifically, they have bought $25,417.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

20.80% of the stock of Natural Alternatives International is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

32.40% of the stock of Natural Alternatives International is held by institutions.

Company Calendar

• Last Earnings: 9/23/2025
• Today: 5/15/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:NAII
• CIK: 787253
• Web: www.nai-online.com
• Phone: (760) 736-7700
• Fax: 760-744-9589
• Employees: 290
• Year Founded: 1980

Profitability

• EPS (Trailing Twelve Months): ($2.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$13.57 million
• Net Margins: -9.06%
• Pretax Margin: -5.91%
• Return on Equity: -8.60%
• Return on Assets: -3.92%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 1.87
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $129.86 million
• Price / Sales: 0.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $11.07 per share
• Price / Book: 0.24

Miscellaneous

• Outstanding Shares: 6,180,000
• Free Float: 4,892,000
• Market Cap: $16.69 million
• Optionable: Not Optionable
• Beta: 0.40